Literature DB >> 10413729

A clinical approach to the use of methotrexate for sarcoidosis.

R P Baughman1, E E Lower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10413729      PMCID： PMC1745538          DOI： 10.1136/thx.54.8.742

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  54 in total

1.  Weekly low-dose methotrexate therapy for cutaneous sarcoidosis.

Authors:  G F Webster; L K Razsi; M Sanchez; J L Shupack
Journal:  J Am Acad Dermatol       Date:  1991-03       Impact factor: 11.527

2.  A controlled trial of prednisone treatment of sarcoidosis.

Authors:  H L Israel; D W Fouts; R A Beggs
Journal:  Am Rev Respir Dis       Date:  1973-04

3.  Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study.

Authors:  A Nyfors; H Jensen
Journal:  Dermatologica       Date:  1983

4.  Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.

Authors:  C A Wallace; A L Smith; D D Sherry
Journal:  J Rheumatol       Date:  1993-10       Impact factor: 4.666

5.  Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial.

Authors:  S L Morgan; J E Baggott; W H Vaughn; J S Austin; T A Veitch; J Y Lee; W J Koopman; C L Krumdieck; G S Alarcón
Journal:  Ann Intern Med       Date:  1994-12-01       Impact factor: 25.391

6.  The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

Authors:  J M Kremer; J K Lee
Journal:  Arthritis Rheum       Date:  1986-07

7.  Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.

Authors:  J M Kremer; G S Alarcón; R W Lightfoot; R F Willkens; D E Furst; H J Williams; P B Dent; M E Weinblatt
Journal:  Arthritis Rheum       Date:  1994-03

8.  Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis.

Authors:  O Kaye; E Palazzo; M Grossin; P Bourgeois; M F Kahn; M G Malaise
Journal:  Br J Rheumatol       Date:  1995-07

9.  Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder.

Authors:  D A White; J A Rankin; D E Stover; R A Gellene; S Gupta
Journal:  Am Rev Respir Dis       Date:  1989-01

10.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245
View more
  23 in total

1.  [Sarcoidosis : Organ involvement, diagnosis, current treatment].

Authors:  B Weidenthaler-Barth; K Steinbrink; A Kümmel; E von Stebut
Journal:  Hautarzt       Date:  2015-07       Impact factor: 0.751

2.  Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

Authors:  Lisa A Maier; Briana Q Barkes; Margaret Mroz; Milton D Rossman; Juliana Barnard; May Gillespie; Allison Martin; Douglas G Mack; Lori Silveira; Richard T Sawyer; Lee S Newman; Andrew P Fontenot
Journal:  Respir Med       Date:  2012-09-11       Impact factor: 3.415

Review 3.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

4.  Diagnosis and Treatment in Neurosarcoidosis.

Authors:  Gökçen Gözübatik-Çelik; Uğur Uygunoğlu; Derya Uludüz; Ersan Atahan; Benan Müsellim; Sabahattin Saip; Aksel Siva
Journal:  Noro Psikiyatr Ars       Date:  2015-03-01       Impact factor: 1.339

Review 5.  Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

Authors:  Merav Lidar; Amir Dori; Yair Levy; Zvi Lidar; Joab Chapman; Pnina Langevitz
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 6.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

Review 7.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 8.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Cardiac sarcoidosis: diagnosis and management.

Authors:  Michelle Bussinguer; Alfred Danielian; Om P Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

Review 10.  Clinical and immunologic components of sarcoidosis.

Authors:  Andrea T Borchers; Calvin So; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.